Submitted by: Submitted by marketresearchri
Views: 10
Words: 810
Pages: 4
Category: Other Topics
Date Submitted: 02/22/2016 10:37 PM
Allergic Rhinitis Industry Share and Size, Trends
and Growth, Analysis and Pipeline Review, H2
2015
Allergic Rhinitis - Pipeline Review, H2 2015
Summary
Global Markets Direct's, 'Allergic Rhinitis - Pipeline Review, H2 2015', provides an overview of the
Allergic Rhinitis's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Allergic Rhinitis,
complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured
news and press releases. It also reviews key players involved in the therapeutic development for Allergic
Rhinitis and special features on late-stage and discontinued projects.
View summary of this report @ http://www.radiantinsights.com/research/allergic-rhinitis-pipelinereview-h2-2015
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations
and featured press releases from company/university sites and industry-specific third party sources, put
together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic
updation following a stringent set of processes that ensures that all the profiles are updated with the latest
set of information. Additionally, processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent developments are captured on a real time
basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and...